Alliance Global Partners initiated coverage on INmune Bio with a new price target
$INMB
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Alliance Global Partners initiated coverage of INmune Bio with a rating of Buy and set a new price target of $20.00